• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非手术牙周治疗对慢性侵袭性牙周炎患者牙龈沟液组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂-2(PAI-2)水平的短期影响。

Short term effects of non-surgical periodontal treatment on gingival crevicular fluid levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in patients with chronic and aggressive periodontitis.

机构信息

Gazi University, Faculty of Dentistry, Department of Periodontology, Ankara, Turkey.

出版信息

Arch Oral Biol. 2013 Apr;58(4):391-6. doi: 10.1016/j.archoralbio.2012.08.008. Epub 2012 Sep 11.

DOI:10.1016/j.archoralbio.2012.08.008
PMID:22980426
Abstract

OBJECTIVE

The purpose of this study was to evaluate the gingival crevicular fluid (GCF) levels of tissue type plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in aggressive periodontitis (AgP), chronic periodontitis (CP) and periodontally healthy control subjects, before (BT) and after (AT) the non-surgical periodontal treatment.

DESIGN

Systemically healthy 12 CP and 13 AgP patients and 20 control subjects were included in this study. Plaque index, gingival index, probing depth and clinical attachment levels were recorded and GCF samples were collected BT and AT. Assays for GCF t-PA and PAI-2 levels were carried out by an enzyme linked immunosorbent assay (ELISA). The χ(2), Wilcoxon and Mann-Whitney U tests and Spearman correlation coefficient were used for data analyses.

RESULTS

Statistically significant reductions in clinical index scores were noted in both periodontitis groups after treatment. No significant differences were detected in GCF levels of t-PA and PAI-2 between CP and AgP groups at either BT or AT. There was a statistically significant decrease in GCF PAI-2 levels in CP after therapy (p<0.01). GCF t-PA levels in CP and AgP groups exhibited significant correlations with PD and CAL measurements at both BT and AT (p<0.01).

CONCLUSION

Significant decrease was detected for GCF PAI-2 levels in CP and clinical parameters in both CP and AgP by non-surgical periodontal treatment.

摘要

目的

本研究旨在评估组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂 2(PAI-2)在侵袭性牙周炎(AgP)、慢性牙周炎(CP)和牙周健康对照受试者的龈沟液(GCF)中的水平,分别在(BT)和(AT)牙周非手术治疗前后。

设计

本研究纳入了 12 名 CP 患者、13 名 AgP 患者和 20 名对照受试者,他们均为系统性健康者。记录菌斑指数、牙龈指数、探诊深度和临床附着水平,并在 BT 和 AT 采集 GCF 样本。采用酶联免疫吸附试验(ELISA)检测 GCF t-PA 和 PAI-2 水平。采用 χ(2)、Wilcoxon 和 Mann-Whitney U 检验和 Spearman 相关系数进行数据分析。

结果

治疗后,两组牙周炎患者的临床指数评分均显著降低。BT 和 AT 时,CP 和 AgP 组的 GCF t-PA 和 PAI-2 水平无显著差异。治疗后 CP 组 GCF PAI-2 水平显著降低(p<0.01)。CP 和 AgP 组 GCF t-PA 水平与 BT 和 AT 时的 PD 和 CAL 测量值呈显著相关(p<0.01)。

结论

非手术牙周治疗后 CP 组 GCF PAI-2 水平和 CP 及 AgP 两组的临床参数均显著降低。

相似文献

1
Short term effects of non-surgical periodontal treatment on gingival crevicular fluid levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in patients with chronic and aggressive periodontitis.非手术牙周治疗对慢性侵袭性牙周炎患者牙龈沟液组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂-2(PAI-2)水平的短期影响。
Arch Oral Biol. 2013 Apr;58(4):391-6. doi: 10.1016/j.archoralbio.2012.08.008. Epub 2012 Sep 11.
2
Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.不同牙周疾病患者龈沟液中组织型纤溶酶原激活物、纤溶酶原激活物抑制剂2、基质金属蛋白酶-3和白细胞介素1-β水平的评估
J Periodontal Res. 2015 Feb;50(1):44-51. doi: 10.1111/jre.12179. Epub 2014 Apr 2.
3
Gingival crevicular fluid tissue/blood vessel-type plasminogen activator and plasminogen activator inhibitor-2 levels in patients with rheumatoid arthritis: effects of nonsurgical periodontal therapy.类风湿关节炎患者龈沟液中组织/血管型纤溶酶原激活物及纤溶酶原激活物抑制剂-2水平:非手术牙周治疗的影响
J Periodontal Res. 2017 Jun;52(3):574-581. doi: 10.1111/jre.12425. Epub 2016 Oct 26.
4
The effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment on gingival crevicular fluid levels of transforming growth factor-beta 1, tissue plasminogen activator and plasminogen activator inhibitor 1 in smoking and non-smoking chronic periodontitis patients: A split-mouth, randomized control study.低水平激光疗法作为非手术牙周治疗的辅助手段对吸烟和非吸烟慢性牙周炎患者龈沟液中转化生长因子-β1、组织纤溶酶原激活物和纤溶酶原激活物抑制剂 1 水平的影响:一项分口、随机对照研究。
J Periodontal Res. 2017 Oct;52(5):872-882. doi: 10.1111/jre.12457. Epub 2017 Apr 10.
5
Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.环孢素A治疗患者龈沟液中的纤溶酶原激活剂和纤溶酶原激活剂抑制剂
J Clin Periodontol. 2004 Jul;31(7):556-61. doi: 10.1111/j.1600-051X.2004.00517.x.
6
Evaluation of t-PA, PAI-2, IL-1beta and PGE(2) in gingival crevicular fluid of rheumatoid arthritis patients with periodontal disease.类风湿性关节炎伴牙周病患者龈沟液中组织型纤溶酶原激活剂、纤溶酶原激活物抑制剂-2、白细胞介素-1β和前列腺素E2的评估
J Clin Periodontol. 2006 Sep;33(9):605-11. doi: 10.1111/j.1600-051X.2006.00961.x. Epub 2006 Jul 20.
7
Gingival crevicular fluid prostaglandin E(2) and thiobarbituric acid reactive substance levels in smokers and non-smokers with chronic periodontitis following phase I periodontal therapy and adjunctive use of flurbiprofen.在接受I期牙周治疗并辅助使用氟比洛芬的慢性牙周炎吸烟者和非吸烟者中,龈沟液中前列腺素E(2)和硫代巴比妥酸反应性物质的水平
J Periodontol. 2007 Jan;78(1):104-11. doi: 10.1902/jop.2007.060217.
8
Plasminogen activator system in smokers and non-smokers with and without periodontal disease.患有和未患有牙周病的吸烟者与非吸烟者中的纤溶酶原激活物系统
J Clin Periodontol. 2005 Apr;32(4):417-24. doi: 10.1111/j.1600-051X.2005.00694.x.
9
Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.I期牙周治疗对龈沟液中基质金属蛋白酶-1和金属蛋白酶组织抑制剂-1水平的影响。
J Periodontol. 2002 May;73(5):487-93. doi: 10.1902/jop.2002.73.5.487.
10
Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment.初始牙周治疗期间吸烟和不吸烟慢性牙周炎患者龈沟液中白细胞介素-17、核因子κB受体活化因子配体及骨保护素水平
J Periodontol. 2009 Aug;80(8):1274-80. doi: 10.1902/jop.2009.090106.

引用本文的文献

1
Impact of low-level laser therapy as an adjunct to non-surgical periodontal treatment on the levels of tissue plasminogen activator and plasminogen activator inhibitor 1 in Stage 3-4, Grade C periodontitis patients: a split-mouth, randomized control study.低水平激光治疗作为非手术牙周治疗的辅助手段对 3-4 期 C 级牙周炎患者组织型纤溶酶原激活物和纤溶酶原激活物抑制剂 1 水平的影响:一项分侧、随机对照研究。
Clin Oral Investig. 2023 Nov;27(11):6439-6449. doi: 10.1007/s00784-023-05248-z. Epub 2023 Sep 15.
2
Oral fluid-based biomarkers in periodontal disease - part 2. Gingival crevicular fluid.牙周病中基于口腔液体的生物标志物 - 第2部分。龈沟液。
J Int Oral Health. 2014 Sep;6(5):126-35.